DNLI
Price
$25.96
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
One day until earnings call
INZY
Price
$4.29
Change
-$0.00 (-0.00%)
Updated
Nov 1 closing price
2 days until earnings call
Ad is loading...

DNLI vs INZY

Header iconDNLI vs INZY Comparison
Open Charts DNLI vs INZYBanner chart's image
Denali Therapeutics
Price$25.96
Change-$0.00 (-0.00%)
Volume$106
CapitalizationN/A
Inozyme Pharma
Price$4.29
Change-$0.00 (-0.00%)
Volume$262.98K
CapitalizationN/A
View a ticker or compare two or three
DNLI vs INZY Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DNLI vs. INZY commentary
Nov 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and INZY is a Hold.

COMPARISON
Comparison
Nov 04, 2024
Stock price -- (DNLI: $25.96 vs. INZY: $4.29)
Brand notoriety: DNLI and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 0% vs. INZY: 121%
Market capitalization -- DNLI: $3.87B vs. INZY: $292.55M
DNLI [@Biotechnology] is valued at $3.87B. INZY’s [@Biotechnology] market capitalization is $292.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $494.31B to $0. The average market capitalization across the [@Biotechnology] industry is $2.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 3 TA indicator(s) are bullish while INZY’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 3 bullish, 6 bearish.
  • INZY’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, INZY is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а -0.73% price change this week, while INZY (@Biotechnology) price change was -10.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

DNLI is expected to report earnings on Mar 03, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.87B) has a higher market cap than INZY($293M). DNLI YTD gains are higher at: 20.969 vs. INZY (0.704). INZY has higher annual earnings (EBITDA): -82.82M vs. DNLI (-486.71M). DNLI has more cash in the bank: 896M vs. INZY (145M). INZY (46.7M) and DNLI (48.8M) have identical debt. DNLI has higher revenues than INZY: DNLI (1.27M) vs INZY (0).
DNLIINZYDNLI / INZY
Capitalization3.87B293M1,322%
EBITDA-486.71M-82.82M588%
Gain YTD20.9690.7042,978%
P/E RatioN/AN/A-
Revenue1.27M0-
Total Cash896M145M618%
Total Debt48.8M46.7M104%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIINZY
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEMMX9.790.09
+0.93%
JHancock Emerging Markets Equity I
FGDKX62.580.45
+0.72%
Fidelity Growth Discovery K
FSQIX9.790.04
+0.41%
Fidelity Advisor Sustainable Intl Eq I
RICIX10.420.02
+0.19%
T. Rowe Price Intl Disciplined Eq I
IVGAX21.760.04
+0.18%
VY® Invesco Growth and Income A

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
N/A
BEAM - DNLI
65%
Loosely correlated
N/A
NTLA - DNLI
58%
Loosely correlated
+4.15%
ALEC - DNLI
58%
Loosely correlated
+2.03%
JANX - DNLI
56%
Loosely correlated
+0.74%
RCKT - DNLI
56%
Loosely correlated
N/A
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
N/A
BEAM - INZY
59%
Loosely correlated
N/A
NTLA - INZY
51%
Loosely correlated
+4.15%
DNLI - INZY
51%
Loosely correlated
N/A
PLRX - INZY
50%
Loosely correlated
+3.20%
ALLO - INZY
50%
Loosely correlated
+6.46%
More